Product
Omnipaque 350mgI/mL
1 clinical trial
6 indications
Indication
Breast CancerIndication
Locally Advanced Breast CancerIndication
Neoadjuvant ChemotherapyIndication
Breast Cancer (HER2-positive)Indication
Triple-Negative Breast CancerIndication
Triple-negative breast cancerClinical trial
Contrast Enhanced Digital Mammography for Predicting Pathologic Complete Response After Neoadjuvant ChemotherapyStatus: Recruiting, Estimated PCD: 2026-07-31